Rebamipide Methyl Ester is a key chemical intermediate used in the synthesis of Rebamipide, a pharmaceutical compound applied in treating gastric ulcers and gastritis by enhancing mucosal protection, reducing inflammation, and promoting mucus production in the gastrointestinal tract. The parent compound, Rebamipide, is also utilized in ophthalmic formulations, such as eye drops, to promote corneal wound healing, treat dry eye disease, and provide antioxidant effects in retinal tissues by boosting mucin production and suppressing inflammatory mediators.